ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/09/05 | 2,416 | 2,416 | 2,365 | 2,377 | -36 | -1.5% | 49,100 |
2018/09/04 | 2,398 | 2,422 | 2,362 | 2,413 | +21 | +0.9% | 49,600 |
2018/09/03 | 2,382 | 2,395 | 2,359 | 2,392 | +10 | +0.4% | 50,900 |
2018/08/31 | 2,390 | 2,392 | 2,366 | 2,382 | -19 | -0.8% | 50,900 |
2018/08/30 | 2,478 | 2,478 | 2,391 | 2,401 | -56 | -2.3% | 69,300 |
2018/08/29 | 2,400 | 2,464 | 2,393 | 2,457 | +67 | +2.8% | 105,500 |
2018/08/28 | 2,410 | 2,426 | 2,386 | 2,390 | +3 | +0.1% | 69,800 |
2018/08/27 | 2,355 | 2,389 | 2,346 | 2,387 | +46 | +2% | 60,800 |
2018/08/24 | 2,368 | 2,388 | 2,335 | 2,341 | +2 | +0.1% | 55,600 |
2018/08/23 | 2,324 | 2,364 | 2,322 | 2,339 | +25 | +1.1% | 55,100 |
2018/08/22 | 2,325 | 2,331 | 2,314 | 2,314 | -21 | -0.9% | 47,400 |
2018/08/21 | 2,307 | 2,342 | 2,305 | 2,335 | +28 | +1.2% | 39,600 |
2018/08/20 | 2,315 | 2,320 | 2,296 | 2,307 | -27 | -1.2% | 79,300 |
2018/08/17 | 2,310 | 2,337 | 2,302 | 2,334 | +24 | +1% | 32,800 |
2018/08/16 | 2,333 | 2,345 | 2,306 | 2,310 | -66 | -2.8% | 78,400 |
2018/08/15 | 2,398 | 2,449 | 2,371 | 2,376 | -50 | -2.1% | 67,200 |
2018/08/14 | 2,372 | 2,427 | 2,372 | 2,426 | +58 | +2.4% | 40,500 |
2018/08/13 | 2,421 | 2,423 | 2,354 | 2,368 | -67 | -2.8% | 66,600 |
2018/08/10 | 2,469 | 2,479 | 2,425 | 2,435 | -34 | -1.4% | 70,800 |
2018/08/09 | 2,500 | 2,524 | 2,454 | 2,469 | -45 | -1.8% | 103,500 |
2018/08/08 | 2,553 | 2,567 | 2,514 | 2,514 | -42 | -1.6% | 135,800 |
2018/08/07 | 2,587 | 2,640 | 2,547 | 2,556 | -76 | -2.9% | 183,500 |
2018/08/06 | 2,484 | 2,677 | 2,484 | 2,632 | +248 | +10.4% | 367,200 |
2018/08/03 | 2,427 | 2,427 | 2,350 | 2,384 | -37 | -1.5% | 68,600 |
2018/08/02 | 2,403 | 2,442 | 2,385 | 2,421 | +18 | +0.7% | 89,500 |
2018/08/01 | 2,500 | 2,519 | 2,396 | 2,403 | -69 | -2.8% | 118,200 |
2018/07/31 | 2,404 | 2,544 | 2,337 | 2,472 | +46 | +1.9% | 563,500 |
2018/07/30 | 2,385 | 2,431 | 2,381 | 2,426 | +26 | +1.1% | 112,400 |
2018/07/27 | 2,343 | 2,416 | 2,334 | 2,400 | +57 | +2.4% | 162,800 |
2018/07/26 | 2,262 | 2,343 | 2,261 | 2,343 | +89 | +3.9% | 140,200 |
2018/07/25 | 2,288 | 2,288 | 2,251 | 2,254 | -21 | -0.9% | 45,500 |
2018/07/24 | 2,296 | 2,304 | 2,270 | 2,275 | -16 | -0.7% | 58,600 |
2018/07/23 | 2,302 | 2,311 | 2,283 | 2,291 | -11 | -0.5% | 38,400 |
2018/07/20 | 2,321 | 2,331 | 2,291 | 2,302 | -19 | -0.8% | 42,400 |
2018/07/19 | 2,354 | 2,354 | 2,318 | 2,321 | -34 | -1.4% | 48,900 |
2018/07/18 | 2,366 | 2,389 | 2,342 | 2,355 | -2 | -0.1% | 77,600 |
2018/07/17 | 2,318 | 2,358 | 2,303 | 2,357 | +39 | +1.7% | 92,200 |
2018/07/13 | 2,316 | 2,344 | 2,301 | 2,318 | +11 | +0.5% | 54,900 |
2018/07/12 | 2,304 | 2,345 | 2,304 | 2,307 | +4 | +0.2% | 84,700 |
2018/07/11 | 2,300 | 2,318 | 2,293 | 2,303 | -1 | ±0% | 103,500 |
2018/07/10 | 2,325 | 2,335 | 2,304 | 2,304 | -18 | -0.8% | 96,000 |
2018/07/09 | 2,316 | 2,330 | 2,302 | 2,322 | +7 | +0.3% | 51,900 |
2018/07/06 | 2,321 | 2,327 | 2,311 | 2,315 | -7 | -0.3% | 90,300 |
2018/07/05 | 2,343 | 2,356 | 2,318 | 2,322 | -25 | -1.1% | 56,400 |
2018/07/04 | 2,311 | 2,357 | 2,311 | 2,347 | +23 | +1% | 47,400 |
2018/07/03 | 2,315 | 2,332 | 2,306 | 2,324 | +9 | +0.4% | 70,300 |
2018/07/02 | 2,384 | 2,384 | 2,315 | 2,315 | -82 | -3.4% | 77,000 |
2018/06/29 | 2,387 | 2,402 | 2,359 | 2,397 | +9 | +0.4% | 52,200 |
2018/06/28 | 2,413 | 2,413 | 2,374 | 2,388 | -24 | -1% | 58,900 |
2018/06/27 | 2,351 | 2,419 | 2,351 | 2,412 | +66 | +2.8% | 88,100 |
1701~
1750
件表示中 / 3771件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 203,600円 | +3.1% | -6.5% | 2.36% | 9.45倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 264,500円 | +21.7% | +999.9% | 0.00% | 12.19倍 | 4.17倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 314,500円 | +5.1% | -7.0% | 2.54% | 20.65倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 247,000円 | +4.1% | -3.1% | 2.35% | 21.46倍 | 1.87倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
杏林製薬 | 152,000円 | -2.4% | -52.3% | 3.75% | 18.19倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム